Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients.

NCT01917851 is registered in ClinicalTrials.gov with OrSense, Ltd. as lead sponsor.

NCT NCT01917851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01917851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients.
Lead sponsor
OrSense, Ltd.
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2011
Completion date
December 31, 2013
Enrollment
300 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia